Product Categories
| Country: | China |
|---|---|
| Tel: | 025-58851786 |
| Mobile: | 17714337195 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| KIF18A-IN-3 | C28H38N4O5S2 | 2600577-49-7 | Details |
| JQAD1 | C48H52F4N6O9 | 2417097-18-6 | Details |
| 4-[(1E)-2-[[(4-CHLOROPHENYL)METHYL]SULFONYL]ETHENYL]-BENZOIC ACID | C16H13ClO4S | 334969-03-8 | Details |
| 2,3-DIHYDROXY-6-METHYL-7-(PHENYLMETHYL)-4-PROPYL-1-NAPHTHALENECARBOXYLIC ACID | C22H22O4 | 213971-34-7 | Details |
| AB 1010 Mesylate | C29H34N6O4S2 | 1048007-93-7 | Details |
| PF-00356231 hydrochloride | C25H21ClN2O3S | 820223-77-6 | Details |
| 1]Benzothieno[2,3-b]pyridine-3-carboxamide, N-[4-(aminosulfonyl)phenyl]-1,2,5,6,7,8-hexahydro-4-hydroxy-2-oxo- | C18H17N3O5S2 | 1359431-16-5 | Details |
| 4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-1-pyrazolyl]-1-azetidinyl]-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide | C23H22F5N7O | 1637677-22-5 | Details |
| KIF18A-IN-2 | C25H34N4O5S2 | 2600559-20-2 | Details |
| CRA-02478 | C21H23N3O5 | 783355-60-2 | Details |
| (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | C22H24N2O7S | 608141-41-9 | Details |
| 2-(4-ethylpiperazin-1-yl)-N-[4-(2-morpholin-4-yl-4-oxochromen-8-yl)dibenzothiophen-1-yl]acetamide | C33H34N4O4S | 881375-00-4 | Details |
| Progabide | C17H16ClFN2O2 | 62666-20-0 | Details |
| Jarin-1 | C28H29N3O4 | 1212704-51-2 | Details |
| L-685 458 | C39H52N4O6 | 292632-98-5 | Details |
| N-[2-[4-(2-fluorophenyl)phenyl]propyl]-2-propanesulfonamide | C18H22FNO2S | 211311-39-6 | Details |
| camonsertib | C21H26N6O3 | 2417489-10-0 | Details |
| AM-5308 | C26H35N5O5S | 2410796-89-1 | Details |
| BRM/BRG1 ATP Inhibitor-2 | C20H20N4O2S2 | 2368900-77-8 | Details |
| TAS1553 | C20H20ClFN4O5S | 2166023-31-8 | Details |
| ABBV-318 | C20H15F4N3O2 | 1802848-94-7 | Details |
| nitroflurbiprofen | C19H20FNO5 | 158836-71-6 | Details |
| (-)-MK-801 MALEATE | C20H19NO4 | 77086-22-7 | Details |
| (2R)-1,1,1-Trifluoro-2-[3-[(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl]sulfonylphenyl]propan-2-ol | C21H21F7N2O3S | 946396-92-5 | Details |
| N-(trans-4-(3-(2-Chlorophenyl)-7-((3-methyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)cyclohexyl)propionamide | C33H41ClN8O2 | 2260886-64-2 | Details |
| Isoquinoline, 6-[[(2R)-hexahydro-2-methyl-1,4-diazocin-1(2H)-yl]sulfonyl]- | C16 H21 N3 O2 S | 1258833-31-6 | Details |
| 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one | C15H15ClN4OS | 1933460-19-5 | Details |
| YB-0158 | C32H35N7NaO7P | 1144043-83-3 | Details |
| BI-4142 | C28H27N9O2 | 2682003-36-5 | Details |
| CUR61414 | C31H42N4O5 | 334998-36-6 | Details |
| RETAPAMULIN | C30H47NO4S | 224452-66-8 | Details |
| 1-((3aR,4S,9bS)-rel-4-(6-Bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)ethanone | C21H18BrNO3 | 881639-98-1 | Details |
| Radotinib | C27H21F3N8O | 926037-48-1 | Details |
| (R)-3-(4-(2-(4-((S)-3-chloro-2-hydroxypropoxy)phenyl)propan-2-yl)phenoxy)propane-1,2-diol | C21H27ClO5 | 1203490-23-6 | Details |
| (+)-5-(4-amino-3-methylphenyl)-7-(2-thiazolyl)-8,9-dihydro-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine | C20H19N5O2S | 923272-18-8 | Details |
| Unii-5H2DV04I6O | C28H39N3O3 | 1369412-66-7 | Details |
| Benzonitrile, 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]- | C22H17F2N5OS | 182760-06-1 | Details |
| 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide | C27H26N4O5S | 801312-28-7 | Details |
| PF 04995274 | C23H32N2O6 | 1331782-27-4 | Details |
| R-Avanafil | C23H26ClN7O3 | 1638497-26-3 | Details |
| "(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide " | C20H21F3N2O2 | 953778-63-7 | Details |
| (R)-(+)-8-methyl-5-(3-methyl-4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine | C18H17N3O4 | 732277-05-3 | Details |
| N6-BENZYLADENOSINE | C17H19N5O4 | 4294-16-0 | Details |
| Apararenone | C17H17FN2O4S | 945966-46-1 | Details |
| Dotinurad | C14H9Cl2NO4S | 1285572-51-1 | Details |
| N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | C29H32F3N7O2 | 1835667-63-4 | Details |
| 4-Piperidinesulfonamide, 1-ethyl-N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]- | C20H29N3O3S | 2260969-36-4 | Details |
| MSC-4106 | C18H12F3N3O2 | 2738542-58-8 | Details |
| INCB 3344 | C29H34F3N3O6 | 1262238-11-8 | Details |
| Neratinib maleate | C34H33ClN6O7 | 915942-22-2 | Details |
| (R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE | C21H21N5O2S | 732278-52-3 | Details |
| Shield-1 | C42H56N2O10 | 914805-33-7 | Details |
| INCB13739 | C28H25N3O4 | 869974-19-6 | Details |
| ATR inhibitor 1 | C16H12F2N8O | 1613200-51-3 | Details |
| Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- | C30H27N5O2 | 2201056-66-6 | Details |
| 4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-1-pyrazolyl]-1-azetidinyl]-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide;phosphoric acid | C23H25F5N7O5P | 1637677-33-8 | Details |
| 1,4-Benzoxazepin-5(2H)-one, 4-[(4-fluorophenyl)methyl]-3,4-dihydro-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)- | C23H18FN3O2 | 2754265-25-1 | Details |
| SOS1-IN-11 | C22H24F3N5O | 2654741-64-5 | Details |
| T-690 | C22H20F3N3O4 | 2597958-02-4 | Details |
| RLX-33 | C24H19ClN4O4 | 2784577-71-3 | Details |
| RILPIVIRINE HCL | C22H19ClN6 | 700361-47-3 | Details |
| 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate | C35H43N5O4 | 864750-70-9 | Details |
| Basmisanil | C21H20FN3O5S | 1159600-41-5 | Details |
| Sunvozertinib | C29H35ClFN7O3 | 2370013-12-8 | Details |
| Sovilnesib | C26H34F2N6O4S | 2410796-79-9 | Details |
| Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, 4,9-bis[[3-(4-methyl-1-piperazinyl)propyl]amino]-2,7-bis[3-(4-morpholinyl)propyl]- | C44H66N10O6 | 1429028-96-5 | Details |
| 3-ethyl-2-[hydroxy(diphenyl)methyl]-N-[(2R)-2-hydroxypropyl]-5-benzimidazolecarboxamide | C26H27N3O3 | 1824637-41-3 | Details |
| 5-(2-AMINO-4-OXO-3-(2-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUIZOLIN-6-YL)-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFOMIDE | C27H18F5N5O4S | 1384097-27-1 | Details |
| NRX-1933 | C14H9F3N6O2 | 2763260-30-4 | Details |
| Benzamide, 2-bromo-N-[2-(4-ethylphenyl)-5-benzoxazolyl]-5-nitro- | C22H16BrN3O4 | 420826-65-9 | Details |
| AGI-43192 | C23H16ClF3N6O | 2377491-54-6 | Details |
| AGI-41998 | C22H16BrF3N4O2 | 2377492-26-5 | Details |
| CID 9828275 | C20H15FN2O6S4 | 603987-59-3 | Details |
| N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[2-methyl-3-(propan-2-yl)-2H-indazol-5-yl]pyrimidin-2-amine | C27H33FN8 | 1868086-40-1 | Details |
| 5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-ethyl-1-piperazinyl)-1-fluoro- | C19H20ClFN4 | 2369979-67-7 | Details |
| JHU 37160 | C19H20ClFN4 | 2369979-68-8 | Details |
| Thieno[2,3-d]pyrimidine, 5-[3-(methylsulfonyl)phenyl]-4-[(1-methyl-1H-tetrazol-5-yl)thio]- | C15H12N6O2S3 | 1222765-97-0 | Details |
| Upacicalcet | C11H14ClN3O6S | 1333218-50-0 | Details |
| 5H-Indeno[5,6-b]furan-3-acetamide, 6,7-dihydro-N-(5-methyl-2-thiazolyl)- | C17H16N2O2S | 790245-61-3 | Details |
| 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]- | C25H27N3O3 | 2291360-73-9 | Details |
| MK-0159 | C20H24N4O3S | 2641484-61-7 | Details |
| Solifenacin | C23H26N2O2 | 242478-37-1 | Details |
| Ethanone, 2-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-1-[(2R)-2-methyl-4-[2-(trifluoromethyl)-4-[2-(trifluoromethyl)-5-pyrimidinyl]-5-thiazolyl]-1-piperazinyl]- | C20H20F6N8OS | 1646267-59-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C22H14ClF3N2O3 | 2639638-67-6 | Details |
| S-Ruxolitinib (INCB018424) | C17H18N6 | 941685-37-6 | Details |
| Cridanimod | C16H20N6O3 | 1446418-48-9 | Details |
| SANGIVAMYCIN | C12H15N5O5 | 18417-89-5 | Details |
| CP-105,696 | C28H28O4 | 158081-99-3 | Details |
| ML-9 HYDROCHLORIDE | C15H18Cl2N2O2S | 105637-50-1 | Details |
| 5-[2-[[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethyl-6-imidazo[1,2-a]pyridinyl]-oxomethyl]amino]ethoxy]-5-oxopentanoic acid | C26H32N4O5 | 1228559-81-6 | Details |
| LY 294002 | C19H18ClNO3 | 934389-88-5 | Details |
| USP8-IN-1 | C18H21N5O3S | 2477650-96-5 | Details |
| AB-836 | C20H15F3N4O2 | 2445597-31-7 | Details |
| EFONIDIPINE | C34H38N3O7P | 111011-63-3 | Details |
| WIN 54461 | C23H25BrN2O3 | 166599-63-9 | Details |
| CBR-5884 | C14H12N2O4S2 | 681159-27-3 | Details |
| EFONIDIPINE | C34H38N3O7P.C2H6O.ClH | 111011-76-8 | Details |
| CS-2696 | C24H24F2N8O2 | 2097416-76-5 | Details |
| 1H-Pyrazolo[3,4-d]pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]- | C27H25F3N8O | 2446480-97-1 | Details |
| tolamolol | C19H24N2O4 | 38103-61-6 | Details |
| Product Total： Product Page： | ||||
| 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 | ||||